These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2360450)

  • 21. [Enoxacin--comparative pharmacokinetics and tissue penetration].
    Sörgel F; Naber KG; Metz R; Morgenroth A
    Infection; 1989; 17 Suppl 1():S14-8. PubMed ID: 2680989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Tranilast [N-(3,4-dimethoxycinnamoyl) anthranilic acid] in secretory otitis media.
    Ogino S; Harada T; Matsunaga T; Tominaga Y
    Ann Allergy; 1992 May; 68(5):407-12. PubMed ID: 1375005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of an antiallergic drug on otitis media with effusion in association with allergic rhinitis. An experimental study.
    Suzuki M; Kerakawauchi H; Kawauchi H; Mogi G
    Ann Otol Rhinol Laryngol; 1999 Jun; 108(6):554-8. PubMed ID: 10378522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetration of cefaclor to adenoid tissue and middle ear fluid in secretory otitis media.
    Edén T; Anari M; Ernstson S; Sundberg L
    Scand J Infect Dis Suppl; 1983; 39():48-52. PubMed ID: 6580733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability and pharmacokinetics of enoxacin.
    Nakamura S; Kurobe N; Sekine Y
    J Chemother; 1989 Jul; 1(4 Suppl):543-4. PubMed ID: 16312524
    [No Abstract]   [Full Text] [Related]  

  • 26. The absorption and disposition of enoxacin in healthy subjects.
    Somogyi AA; Bochner F
    J Clin Pharmacol; 1988 Aug; 28(8):707-13. PubMed ID: 3216037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of enoxacin into lung tissue.
    Newsom SW; Eden CG; Wells FC; Meredith P
    J Antimicrob Chemother; 1989 Jan; 23(1):113-5. PubMed ID: 2745246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penetration of ceftazidime into middle ear fluid in children with otitis media with effusion.
    Bégué P; Garabédian EN; Bertrand C; Aubert B; Chiche D
    Laryngoscope; 1998 May; 108(5):662-4. PubMed ID: 9591542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion].
    Naber KG; Sörgel F; Kees F; Schumacher H; Sigl G; Zürcher J; Berger S
    Infection; 1989; 17 Suppl 1():S30-6. PubMed ID: 2478481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.
    Iino Y; Usubuchi H; Kodama K; Kanazawa H; Takizawa K; Kanazawa T; Ohta Y
    Otol Neurotol; 2010 Jan; 31(1):100-4. PubMed ID: 19816234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
    Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
    Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Otitis media: the middle ear effusion total white cell count.
    Ostfeld E
    Am J Otol; 1984 Jul; 5(5):382-6. PubMed ID: 6540996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enoxacin: a new fluoroquinolone.
    Jaber LA; Bailey EM; Rybak MJ
    Clin Pharm; 1989 Feb; 8(2):97-107. PubMed ID: 2645085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oxatomide on otitis media with effusion--an experimental study.
    Tanaka T; Kurono Y; Kawauchi H; Mogi G
    Acta Otolaryngol; 1995 Jul; 115(4):532-8. PubMed ID: 7572131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bronchopulmonary penetration of enoxacin].
    Loos U; Sörgel F; Marklein G; Kraeft H
    Infection; 1989; 17 Suppl 1():S23-4. PubMed ID: 2807559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial.
    Tapiainen T; Kujala T; Renko M; Koivunen P; Kontiokari T; Kristo A; Pokka T; Alho OP; Uhari M
    JAMA Pediatr; 2014 Jul; 168(7):635-41. PubMed ID: 24797294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MALDI-TOF mass spectrometry reveals a highly complex bacterial profile of otitis media with effusion.
    Papp Z; Elgabsi H; Tóth L
    Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():189-92. PubMed ID: 27260605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is secretory otitis media a single disease entity?
    Sadé J; Russo E; Fuchs C; Cohen D
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):342-7. PubMed ID: 12731629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in middle ear effusion during early phase of acute otitis media.
    Karjalainen H; Koskela M; Luotonen J; Herva E; Sipilä P
    Acta Otolaryngol; 1990; 109(1-2):111-8. PubMed ID: 2106760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.